Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

Clinical trial NCT00963235 · COMPLETED

Trial details

NCT number: NCT00963235
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections Pneumococcal Infections

Start date: 2009-11-01
Primary completion: 2012-05-01
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.